Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXER3U
|
||||
Drug Name |
(S)-4-Bromo-N-[5-(2-fluoro-phenyl)-1-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-benzamide
|
||||
Synonyms |
CHEMBL1907850
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C23H17BrFN3O2
|
||||
Canonical SMILES |
CN1C(=O)[C@@H](NC(=O)c2ccc(Br)cc2)N=C(c3ccccc3F)c4ccccc14
|
||||
InChI |
InChI=1S/C23H17BrFN3O2/c1-28-19-9-5-3-7-17(19)20(16-6-2-4-8-18(16)25)26-21(23(28)30)27-22(29)14-10-12-15(24)13-11-14/h2-13,21H,1H3,(H,27,29)/t21-/m1/s1
|
||||
InChIKey |
ARRVGGQZILZZEJ-OAQYLSRUSA-N
|
||||
Target and Pathway | |||||
Target(s) | Gastrin/cholecystokinin type B receptor | Target Info | [1587926] | ||
Cholecystokinin receptor type A | Target Info | [1587926] | |||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.